Figure S5 from Medium-throughput Drug Screening of Patient-derived Organoids from Colorectal Peritoneal Metastases to Direct Personalized TherapyVignesh Narasimhan, Susan L. Woods, Josephine A. Wright et al.|Unknown|2023Cited by 1
Figure S3 from Medium-throughput Drug Screening of Patient-derived Organoids from Colorectal Peritoneal Metastases to Direct Personalized TherapyVignesh Narasimhan, Susan L. Woods, Josephine A. Wright et al.|Unknown|2023Cited by 0
Figure S2 from Medium-throughput Drug Screening of Patient-derived Organoids from Colorectal Peritoneal Metastases to Direct Personalized TherapyVignesh Narasimhan, Susan L. Woods, Josephine A. Wright et al.|Unknown|2023Cited by 0
Figure S1 from Medium-throughput Drug Screening of Patient-derived Organoids from Colorectal Peritoneal Metastases to Direct Personalized TherapyVignesh Narasimhan, Susan L. Woods, Josephine A. Wright et al.|Unknown|2023Cited by 0
Table S1 from Medium-throughput Drug Screening of Patient-derived Organoids from Colorectal Peritoneal Metastases to Direct Personalized TherapyVignesh Narasimhan, Susan L. Woods, Josephine A. Wright et al.|Unknown|2023Cited by 0